Vitamins B status and antioxidative defense in patients with chronic hepatitis B or hepatitis C virus infection

European Journal of Nutrition

Volumn 50, Issue 7, 2011, Pages 499-506

  Lin, Chun Che ^a,b   Liu, Wen Hu ^b   Wang, Zhi Hong ^b   Yin, Mei Chin ^c,d  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

B vitamins; Hepatitis B virus; Hepatitis C virus; Lipid metabolism; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CHOLESTEROL; COPPER; FATTY ACID; FOLIC ACID; GHRELIN; GLUTATHIONE PEROXIDASE; LACTATE DEHYDROGENASE; PYRIDOXINE; RIBOFLAVIN; SELENIUM; SUPEROXIDE DISMUTASE; VITAMIN B GROUP; ZINC;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; COPPER BLOOD LEVEL; ENZYME ACTIVITY; ERYTHROCYTE COUNT; FATTY ACID BLOOD LEVEL; FEMALE; HEALTH STATUS; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; OXIDATIVE STRESS; SCORING SYSTEM; SELENIUM BLOOD LEVEL; TRACE METAL BLOOD LEVEL; VITAMIN BLOOD LEVEL; ZINC BLOOD LEVEL;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OXIDATIVE STRESS; VITAMIN B COMPLEX;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 80053905099     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-010-0156-1     Document Type: Article

References (32)

1. A Tan SH Yeh CJ Liu C Cheung PJ Chen 2008 Viral hepatocarcinogenesis: from infection to cancer Liver Int 28 175 188 10.1111/j.1478-3231.2007.01652.x 1:CAS:528:DC%2BD1cXivFKit7k%3D (Pubitemid 351201032)
2. J Fung CL Lai MF Yuen 2009 Hepatitis B and C virus-related carcinogenesis Clin Microbiol Infect 15 964 970 10.1111/j.1469-0691.2009.03035.x 1:CAS:528:DC%2BD1MXhsFChtb3E
3. YS Lim WR Kim 2008 The global impact of hepatic fibrosis and end-stage liver disease Clin Liver Dis 12 733 746 10.1016/j.cld.2008.07.007
4. JT Wu JG Kral 2004 Ghrelin: integrative neuroendocrine peptide in health and disease Ann Surg 239 464 474 10.1097/01.sla.0000118561.54919.61 (Pubitemid 38372762)
5. CC Lin MC Yin 2007 B vitamins deficiency and decreased anti-oxidant state in patients with liver cancer Eur J Nutr 46 293 299 10.1007/s00394-007-0665-8 1:CAS:528:DC%2BD2sXhtVSqsL%2FM (Pubitemid 47125269)
6. J Nair P Srivatanakul C Haas A Jedpiyawongse T Khuhaprema HK Seitz H Bartsch 2010 High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases Mutat Res 683 23 28 10.1016/j.mrfmmm.2009.10.002 1:CAS:528:DC%2BD1MXhsFGgurzM
7. K Swietek J Juszczyk 1997 Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis J Viral Hepat 4 139 141 1:STN:280:DyaK2s3ltFGruw%3D%3D (Pubitemid 127736549)
8. AM Chrobot A Szaflarska-Szczepanik G Drewa 2000 Antioxidant defense in children with chronic viral hepatitis B and C Med Sci Monit 6 713 718 1:CAS:528:DC%2BD3cXmvVSksLs%3D
9. N Fujita R Sugimoto N Ma H Tanaka M Iwasa Y Kobayashi S Kawanishi S Watanabe M Kaito Y Takei 2008 Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C J Viral Hepat 15 498 507 10.1111/j.1365-2893.2008.00972.x 1:STN:280:DC%2BD1czovV2rsA%3D%3D (Pubitemid 351798987)
10. AM Di Bisceglie ML Shiffman GT Everson KL Lindsay JE Everhart EC Wright WM Lee AS Lok HL Bonkovsky TR Morgan MG Ghany C Morishima KK Snow JL Dienstag HALT-C Trial Investigators 2008 Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon N Engl J Med 359 2429 2441 10.1056/NEJMoa0707615 1:CAS:528:DC%2BD1cXhsVGns7jN
11. Department of Health (1998) Taiwan nutrient databases 1998. Department of Health, Executive Yuan, Taipei
12. D Talwar T Ha J Cooney J Cooney C Brownlee DS O'Reilly 1998 A routine method for the simultaneous measurement of retinol, α-tocopherol and five carotenoids in human plasma by reverse phase HPLC Clin Chim Acta 270 85 100 10.1016/S0009-8981(97)00224-6 1:CAS:528:DyaK1cXht1Wiur4%3D (Pubitemid 28095682)
13. A Karlsen R Blomhoff TE Gundersen 2005 High-throughput analysis of vitamin C in human plasma with the use of HPLC with monolithic column and UV-detection J Chromatogr B Analyt Technol Biomed Life Sci 824 132 138 10.1016/j.jchromb.2005.07.008 1:CAS:528:DC%2BD2MXpslynsbs%3D (Pubitemid 41215590)
14. N Prajda G Weber 1975 Malignant transformation-linked imbalance: decreased XO activity in hepatomas FEBS Lett 59 245 249 10.1016/0014-5793(75) 80385-1 1:CAS:528:DyaE28XktFKrsg%3D%3D
15. D Talwar H Davidson J Cooney D St JO'Reilly 2000 Vitamin B (1) status assessed by direct measurement of thiamin pyrophosphate in erythrocytes or whole blood by HPLC: comparison with erythrocyte transketolase activation assay Clin Chem 46 704 710 1:CAS:528:DC%2BD3cXjsVKksbk%3D (Pubitemid 30318427)
16. AJ Speek F van Schaik J Schrijver WH Schreurs 1982 Determination of the B2 vitamer flavin-adenine dinucleotide in whole blood by high-performance liquid chromatography with fluorometric detection J Chromatogr 228 311 316 10.1016/S0378-4347(00)80446-6 1:CAS:528:DyaL38XhsFymtrg%3D (Pubitemid 12076010)
17. D Talwar T Quasim DC McMillan J Kinsella C Williamson DS O'Reilly 2003 Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation J Chromatogr B Analyt Technol Biomed 792 333 343 10.1016/S1570-0232(03)00320-9 1:CAS:528:DC%2BD3sXlt1aktLw%3D (Pubitemid 36830883)
18. YC Hong KH Lee CH Yi EH Ha DC Christiani 2002 Genetic susceptibility of term pregnant women to oxidative damage Toxicol Lett 129 255 262 10.1016/S0378-4274(02)00014-0 1:CAS:528:DC%2BD38XhvVWnsbs%3D (Pubitemid 34219168)
19. M Konishi M Iwasa J Araki Y Kobayashi A Katsuki Y Sumida N Nakagawa Y Kojima S Watanabe Y Adachi M Kaito 2006 Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane J Gastroenterol Hepatol 21 1821 1825 10.1111/j.1440-1746.2006.04420.x 1:CAS:528:DC%2BD2sXkt1aqsQ%3D%3D (Pubitemid 44657003)
20. R Pellicano G Puglisi A Ciancio F Balzola G Saracco G Ciccone I Baldi ML Abate A Smedile M Rizzetto 2008 Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection? J Med Virol 80 628 631 10.1002/jmv.21123 1:CAS:528:DC%2BD1cXktFaks70%3D (Pubitemid 351358560)
21. K Moriya Y Shintani H Fujie H Miyoshi T Tsutsumi H Yotsuyanagi S Iino S Kimura K Koike 2003 Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan Hepatol Res 25 371 376 10.1016/S1386-6346(02)00309-1 1:CAS:528:DC%2BD3sXivFGit78%3D (Pubitemid 36519283)
22. KH Kim HJ Shin K Kim HM Choi SH Rhee HB Moon HH Kim US Yang DY Yu J Cheong 2007 Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma Gastroenterology 132 1955 1967 10.1053/j.gastro.2007.03.039 1:CAS:528:DC%2BD2sXmsVymsb4%3D (Pubitemid 46677949)
23. AP Russell P Schrauwen E Somm G Gastaldi MK Hesselink G Schaart E Kornips SK Lo D Bufano JP Giacobino P Muzzin M Ceccon C Angelini L Vergani 2003 Decreased fatty acid beta-oxidation in riboflavin-responsive, multiple acylcoenzyme A dehydrogenase-deficient patients is associated with an increase in uncoupling protein-3 J Clin Endocrinol Metab 88 5921 5926 10.1210/jc.2003-030885 1:CAS:528:DC%2BD3sXhtVSgsrvO (Pubitemid 38033073)
24. AA Morris DM Turnbull 1998 Fatty acid oxidation defects in muscle Curr Opin Neurol 11 485 490 10.1097/00019052-199810000-00011 1:STN:280: DyaK1M%2FmsVCltg%3D%3D (Pubitemid 28542983)
25. H Hosoda M Kojima K Kangawa 2006 Biological, physiological, and pharmacological aspects of ghrelin J Pharmacol Sci 100 398 410 10.1254/jphs.CRJ06002X 1:CAS:528:DC%2BD28XmvVWqu7Y%3D (Pubitemid 44609531)
26. I Legakis J Stathopoulos T Matzouridis GP Stathopoulos 2009 Decreased plasma ghrelin levels in patients with advanced cancer and weight loss in comparison to healthy individuals Anticancer Res 29 3949 3952
27. AM Gori F Sofi R Marcucci B Giusti G Franco Gensini R Abbate 2007 Association between homocysteine, vitamin B(6) concentrations and inflammation Clin Chem Lab Med 45 1728 1736 10.1515/CCLM.2007.347 1:CAS:528: DC%2BD1cXjtV2hug%3D%3D (Pubitemid 350237614)
28. R Ullegaddi HJ Powers SE Gariballa 2004 B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke Clin Sci (Lond) 107 477 484 10.1042/CS20040134 1:CAS:528:DC%2BD2cXovVOhtLk%3D (Pubitemid 39506739)
29. RS Rivlin 1986 Riboflavin Adv Exp Med Biol 206 349 355 1:CAS:528:DyaL2sXkvFGlt78%3D
30. C McGowan 1989 Influence of vitamin B6 status on aspects of lead poisoning in rats Toxicol Lett 47 87 93 10.1016/0378-4274(89)90088-X 1:CAS:528:DyaL1MXktVahu7w%3D (Pubitemid 19096891)
31. C Bolukbas FF Bolukbas M Horoz M Aslan H Celik O Erel 2005 Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection BMC Infect Dis 5 95 102 10.1186/1471-2334-5-95 (Pubitemid 41637632)
32. J Choi JH Ou 2006 Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus Am J Physiol Gastrointest Liver Physiol 290 847 851 10.1152/ajpgi.00522.2005